Search & Analyze

Laurus Labs Ltd.

HealthcarePharmaceuticals & Drugs

www.lauruslabs.com BSE: 540222NSE: LAURUSLABS

₹1,974.00BSE1.20%

23 Oct, 4:01 PM

₹1,974.00

₹1.07L Cr

97.55

18.91

18.31%

₹2,007.15

₹1,933.00

₹2,087.00

₹901.85

Customise metrics bar

Laurus Labs Ltd. (LAURUSLABS) share price closed at ₹1,974.00 on the BSE on Friday, October 23, 2026, down by 1.20% from its of ₹1,998.00. In that session LAURUSLABS reached a of 2,007.15 and of 1,933.00. The for the session was 1,958.51. The stands at 1,942.75 and is at 1,421.52. Looking at , the stock ended the session moving sideways.

Stock Overview

Symbol

LAURUSLABS

₹1,998.00

₹1,958.51

₹1,942.75

Price 1.61% above

₹1,421.52

Price 38.87% above

55.29% of range

₹1,933.00₹2,007.15

90.47% of range

₹901.85₹2,087.00

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,743.00	34.58	4,18,204.09	0.92	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	8,984.00	81.54	2,38,496.97	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,482.00	80.26	1,70,480.87	0.85	534.00	-9.64%	4,979.00	50.79%	19.27
ZYDUSLIFE ZYDUSLIFE	1,127.85	24.93	1,12,503.47	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,337.00	32.04	1,08,012.30	0.97	785.55	-39.18%	7,119.28	2.33%	16.00
Laurus Labs Ltd. LAURUSLABS	1,974.00	97.55	1,06,657.63	0.10	362.07	123.94%	2,026.31	29.10%	18.20
DR.REDDY'S DRREDDY	1,224.50	36.50	1,02,206.60	0.65	913.20	-31.69%	8,697.80	-1.48%	13.75
MANKIND MANKIND	2,217.00	44.83	91,572.10	0.05	574.09	29.12%	4,030.59	12.89%	13.24

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,194.91	1,223.70	1,415.05	1,720.30	1,569.57	1,653.47	1,778.29	1,811.57	2,026.31
Expenses	1,023.71	1,045.37	1,129.90	1,299.70	1,187.44	1,250.21	1,298.08	1,299.46	1,388.04
	171.20	178.33	285.15	420.60	382.13	403.26	480.21	512.11	638.27
	14.33%	14.57%	20.15%	24.45%	24.35%	24.39%	27.00%	28.27%	31.50%
	2.51	4.60	9.42	58.57	10.43	26.96	5.76	11.80	9.18
Interest	49.19	52.61	57.80	56.40	51.50	40.00	38.79	40.44	42.22
	106.06	107.51	106.09	110.43	116.84	120.49	120.62	122.10	123.87
	18.93	25.04	133.01	311.24	224.82	270.47	325.33	361.55	481.44
	33.02%	20.33%	30.13%	25.21%	28.08%	28.09%	22.58%	21.98%	24.79%
	12.51	19.84	92.30	233.67	163.02	194.97	251.66	279.14	367.60
	0.23	0.37	1.71	4.33	3.02	3.61	4.66	5.17	6.80

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	4,935.57	6,040.55	5,040.83	5,553.96	6,812.90
	4,935.57	6,040.55	5,040.83	5,553.96	6,812.90
EXPENDITURE :
Increase/Decrease in Stock	-221.17	22.04	-100.88	-55.93	-271.44
Raw Material Consumed	2,355.06	2,707.63	2,475.23	2,451.01	2,871.96
Power & Fuel Cost	204.47	324.10	338.15	323.40	371.19
Employee Cost	469.55	557.43	614.85	676.44	815.39
Other Manufacturing Expenses	441.18	522.90	611.80	648.97	733.32
General and Administration Expenses	146.49	151.15	157.89	201.69	267.73
Selling and Distribution Expenses	101.98	116.14	134.49	170.95	141.32
Miscellaneous Expenses	15.58	46.97	31.80	82.15	105.72
	3,513.14	4,448.36	4,263.33	4,498.68	5,035.19
Operating Profit (Excl OI)	1,422.43	1,592.19	777.50	1,055.28	1,777.71
	15.30	6.00	26.34	75.10	54.95
	1,437.73	1,598.19	803.84	1,130.38	1,832.66
Interest	102.39	165.17	182.90	216.00	170.73
PBDT	1,335.34	1,433.02	620.94	914.38	1,661.93
	251.49	324.08	384.58	430.09	480.05
Profit Before Taxation & Exceptional Items	1,083.85	1,108.94	236.36	484.29	1,181.88
	1,083.85	1,108.94	236.36	484.29	1,181.88
Provision for Tax	251.42	312.30	68.15	129.88	292.03
	832.43	796.64	168.21	354.41	889.85
Extra items				0.00	0.00
Minority Interest	-4.71	-3.27	-1.72	-0.02	-1.35
Share of Associate	-0.20	-3.21	-5.94	3.93	0.29
Other Consolidated Items		-5.63	-2.87
Consolidated Net Profit	827.52	784.53	157.68	358.32	888.79
Profit Balance B/F	1,883.29	2,624.95	3,302.01	3,314.95	3,626.49
Appropriations	2,710.81	3,409.48	3,459.69	3,673.27	4,515.28
Equity Dividend %	100.00%	100.00%	40.00%	60.00%	100.00%
	15.40	14.56	2.93	6.64	16.46
Adjusted EPS	15.40	14.56	2.93	6.64	16.46

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	107.47	107.73	107.79	107.85	107.97
Share Warrants & Outstandings	9.17	12.08	21.47	26.05	24.98
Total Reserves	3,234.55	3,917.72	3,981.69	4,338.66	5,167.11
Reserve excluding Revaluation Reserve	3,234.55	3,917.72	3,981.69	4,338.66	5,167.11
	3,351.19	4,037.53	4,110.95	4,472.56	5,300.06
Minority Interest	7.86	11.13	4.62	129.96	131.30
Secured Loans	596.34	761.42	798.23	645.58	611.34
Deferred Tax Assets / Liabilities	69.11	82.45	57.04	31.87	29.38
Other Long Term Liabilities	189.86	254.14	210.44	409.79	671.59
Long Term Provisions	72.67	81.47	93.47	106.09	132.09
Total Non-Current Liabilities	927.98	1,179.48	1,159.18	1,193.33	1,444.40
Trade Payables	876.37	710.65	1,051.24	958.49	1,252.09
Other Current Liabilities	839.73	640.75	610.73	779.68	798.54
Short Term Borrowings	910.72	995.77	1,389.29	1,715.01	1,492.64
Short Term Provisions	54.19	85.09	61.02	86.54	92.16
Total Current Liabilities	2,681.01	2,432.26	3,112.28	3,539.72	3,635.43
Total Liabilities	6,968.04	7,660.40	8,387.03	9,335.57	10,511.19
Gross Block	3,750.20	4,794.82	5,652.20	6,284.33	6,970.29
Less: Accumulated Depreciation	1,097.73	1,386.20	1,762.19	2,161.11	2,599.65
Net Block	2,652.47	3,408.62	3,890.01	4,123.22	4,370.64
Capital Work in Progress	813.22	550.78	422.84	458.36	773.28
Non Current Investments	30.81	49.90	123.98	233.26	309.27
Long Term Investment	30.81	49.90	123.98	233.26	309.27
Long Term Loans & Advances	84.11	160.58	83.50	163.40	201.28
Other Non Current Assets	42.82	28.84	31.73	25.01	27.51
Total Non-Current Assets	3,623.43	4,198.72	4,552.06	5,003.25	5,681.98
Inventories	1,760.30	1,684.81	1,845.41	1,936.54	2,342.16
Sundry Debtors	1,354.18	1,580.44	1,662.92	2,007.16	2,155.04
Cash and Bank	75.94	48.46	141.65	144.21	113.70
Other Current Assets	19.71	39.07	37.83	37.35	34.17
Short Term Loans and Advances	134.48	108.90	147.16	207.06	184.14
Total Current Assets	3,344.61	3,461.68	3,834.97	4,332.32	4,829.21
Net Current Assets (Including Current Investments)	663.60	1,029.42	722.69	792.60	1,193.78
Total Assets	6,968.04	7,660.40	8,387.03	9,335.57	10,511.19
Contingent Liabilities	118.80	152.23	153.92	425.90	420.55
Total Debt	1,732.03	1,971.97	2,507.05	2,693.09	2,397.49
	62.19	74.73	75.88	82.46	97.71
Adjusted Book Value	62.19	74.73	75.88	82.46	97.71

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	1,083.85	1,108.94	236.36	484.29	1,181.88
Adjustment	351.13	485.71	562.92	629.50	710.40
Changes In working Capital	-341.61	-315.26	-29.02	-374.60	25.08
Cash Flow after changes in Working Capital	1,093.37	1,279.39	770.26	739.19	1,917.36
Cash Flow from Operating Activities	911.10	993.90	665.69	601.65	1,623.50
Cash Flow from Investing Activities	-914.34	-996.06	-822.42	-681.72	-1,088.66
Cash Flow from Financing Activitie	30.26	-26.64	249.83	39.28	-524.72
Net Cash Inflow / Outflow	27.02	-28.80	93.10	-40.79	10.12
Opening Cash & Cash Equivalents	48.46	75.35	45.67	138.94	99.54
Effect of Foreign Exchange Fluctuations	-0.13	-0.88	0.17	1.39	3.00
Closing Cash & Cash Equivalent	75.35	45.67	138.94	99.54	112.66

Ratios

Valuation

97.55

18.91

52.19

14.67

20.24

104.37

Profitability

18.31

18.20

8.97

26.09

13.06

Leverage & Liquidity

0.45

1.33

7.92

Returns

0.10

0.69

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	27.18	27.18	27.62	27.62	27.59	27.59	27.49	27.49	27.47	27.47
	39.23	39.13	38.30	37.29	37.64	37.89	38.94	39.79	41.74	42.70
	33.59	33.69	34.08	35.09	34.78	34.51	33.56	32.71	30.79	29.83
	72.82	72.82	72.38	72.38	72.41	72.41	72.51	72.51	72.53	72.53
No. of Shareholders	3,24,059	3,09,063	2,92,214	2,92,905	2,80,223	2,83,678	2,80,756	2,92,281	2,91,653	3,11,892

Mutual Funds Invested(222)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 95 active funds hold 6.64% in Laurus Labs Ltd., contributing to ₹7.11K Cr of holdings

Fund				As of
MI Mirae Asset Large & Midcap Fund - Growth - Direct PlanLarge & Mid Cap	1,755.60	4.10	88,66,688	Sep '26
MI Mirae Asset ELSS Tax Saver Fund - Growth - Direct PlanEquity - ELSS - Tax Saver Fund	1,120.36	4.55	56,58,404	Sep '26
MI Mirae Asset Midcap Fund - Growth - Direct PlanMid Cap Fund	842.13	4.31	42,53,201	Sep '26
UT UTI Nifty200 Momentum 30 Index Fund - Growth - Direct PlanIndex Funds - Other	520.66	6.54	26,29,596	Sep '26
HS HSBC Small Cap Fund - Growth - Direct PlanSmall cap Fund	253.86	1.37	12,82,134	Sep '26
SB SBI Healthcare Opportunities Fund - Growth - Direct PlanPharma & Health Care	237.60	4.05	12,00,000	Sep '26
MI Mirae Asset Aggressive Hybrid Fund - Growth - Direct PlanHybrid - Aggressive Hybrid Fund	195.99	2.12	9,89,827	Sep '26
MI Mirae Asset Healthcare Fund - Growth - Direct PlanPharma & Health Care	192.60	5.51	9,72,748	Sep '26
AX Axis Small Cap Fund - Growth - Direct PlanSmall cap Fund	178.20	0.58	9,00,000	Sep '26
WC WhiteOak Capital Mid Cap Fund - Growth - Direct PlanMid Cap Fund	165.55	2.20	8,36,111	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-13	Board Meeting	Quarterly Results & Interim Dividend
2026-07-09	Board Meeting	Quarterly Results
2026-06-08	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Laurus Labs Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

13 members across the board and senior leadership

G Venkateswar Reddy

Company Secretary & Compliance Officer

—

Ravindranath Kancherla

Chairman

₹26.00 L

Mar '26

Satyanarayana Chava

Executive Director & Chief Executive Officer

₹24.80 Cr

Mar '26

V Ravi Kumar

Executive Director & Chief Financial Officer

₹6.60 Cr

Mar '26

CV Lakshmana Rao

Executive Director

₹4.56 Cr

Mar '26

Krishna Chaitanya Chava

Executive Director

₹2.20 Cr

Mar '26

Soumya Chava

Executive Director

₹1.35 Cr

Mar '26

Aruna Bhinge

Non Executive Independent Director

₹30.00 L

Mar '25

Rajesh Koshy Chandy

Non Executive Independent Director

₹43.89 L

Mar '25

Karnam Sekar

Non Executive Independent Director

₹27.00 L

Mar '26

Ramesh Subrahmanian

Non Executive Independent Director

₹30.00 L

Mar '26

Sutapa Banerjee

Independent Director

—

Shekhar Chintamani Mande

Independent Director

—

LAURUSLABS Latest News

News

4 of 4 articles

COMPANY15 Oct 2026 · 12:08

Laurus Labs invests Rs 107.80 crore in KRKA Pharma

The percentage of shareholding by the company shall remain same at 49% post this investment

COMPANY7 Oct 2026 · 17:39

Laurus Labs invests Rs 12.09 crore in KRPL

Consequent to this investment, the total holding of the company in KRPL is 2,11,68,000 equity shares of Rs 10 each

EQUITY31 Aug 2026 · 17:44

Laurus Labs submits analyst meet intimation

EQUITY8 Jun 2026 · 17:14

Laurus Labs informs about AGM

LAURUSLABS

₹1,974.00

-1.2%